Melanoma-specific antigen-associated antitumor antibody reactivity as an immune-related biomarker for targeted immunotherapies

BACKGROUND: Immunotherapies, including cancer vaccines and immune checkpoint inhibitors have transformed the management of many cancers. However, a large number of patients show resistance to these immunotherapies and current research has provided limited findings for predicting response to precisio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rähni, Annika, Jaago, Mariliis, Sadam, Helle, Pupina, Nadežda, Pihlak, Arno, Tuvikene, Jürgen, Annuk, Margus, Mägi, Andrus, Timmusk, Tõnis, Ghaemmaghami, Amir M., Palm, Kaia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095616/
https://www.ncbi.nlm.nih.gov/pubmed/35603273
http://dx.doi.org/10.1038/s43856-022-00114-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095616/
https://www.ncbi.nlm.nih.gov/pubmed/35603273
http://dx.doi.org/10.1038/s43856-022-00114-7

Ejemplares similares